ReviewJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
Monitoring chemotherapy-induced cardiotoxicity: role of cardiac nuclear imaging.
Review in Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 1 synthesis or guideline pooled it, 62 citations in OpenAlex.
- MIBG cardiac imaging compared to ejection fraction in evaluation of cardiotoxicity: a systematic review.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2022Pooled it
- How to Use Multimodality Imaging in Cardio-Oncology.Journal of cardiovascular development and disease · 2026Review
- Article
- The role of inflammation and antioxidant defenses in the cardiotoxicity of doxorubicin in elderly CD-1 male mice.Archives of toxicology · 2023Article
- Early detection of cancer therapy cardiotoxicity by radionuclide angiography: An update.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2023Review
- Nuclear medicine in the assessment and prevention of cancer therapy-related cardiotoxicity: prospects and proposal of use by the European Association of Nuclear Medicine (EANM).European journal of nuclear medicine and molecular imaging · 2023Article
- Detection of Anticancer Drug-Induced Cardiotoxicity Using VCAM1-Targeted Nanoprobes.ACS applied materials & interfaces · 2022Article
- Doxorubicin-induced apoptosis enhances monocyte infiltration and adverse cardiac remodeling in diabetic animals.Canadian journal of physiology and pharmacology · 2022Article
- Shining Damaged Hearts: Immunotherapy-Related Cardiotoxicity in the Spotlight of Nuclear Cardiology.International journal of molecular sciences · 2022Review
- Personality Traits and Cardiotoxicity Arising From Cancer Treatments: An Hypothesized Relationship.Frontiers in psychology · 2021Article
- Cardiovascular imaging in cardio-oncology.Journal of thoracic disease · 2018Review
- Apoptosis and remodeling in adriamycin-induced cardiomyopathy rat model.Korean journal of pediatrics · 2017Article
- Assessment of late anthracycline-induced cardiotoxicity byJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2017Article
- Diagnostic Strategies for Early Recognition of Cancer Therapeutics-Related Cardiac Dysfunction.Clinical Medicine Insights. Cardiology · 2017Review
- Doxorubicin induced heart failure: Phenotype and molecular mechanisms.International journal of cardiology. Heart & vasculature · 2016Article
- Multimodality Imaging in Cardiooncology.Journal of oncology · 2015Review
- Nuclear imaging in detection and monitoring of cardiotoxicity.World journal of radiology · 2014Review
- Imaging of early modification in cardiomyopathy: the doxorubicin-induced model.The international journal of cardiovascular imaging · 2013Review
- Traditional and novel methods to assess and prevent chemotherapy-related cardiac dysfunction noninvasively.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2013Review
- Cardiac imaging approaches to evaluate drug-induced myocardial dysfunction.American heart journal · 2012Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cardiotoxicity may result from a range of chemotherapeutic agents. The prevalence of cardiotoxicity from certain cytotoxic agents is reported to be significantly high. In addition to serious side effects and increased long-lasting morbidity and mortality, dose limitation and suboptimal usage is an important adverse effect. Nuclear cardiac imaging has played a quintessential and important role in identifying patients at risk and in the prevention and reduction of cardiac injury resulting from cytotoxic agents. Despite exploring a number of other diagnostic imaging or biochemical tools for identification of cardiac injury, nuclear cardiac imaging in the form of radionuclide angiocardiography continues to be the most suitable and cost-effective tool for reducing the prevalence of cases of cardiac dysfunction resulting from chemotherapy. This article reviews the prevalence, mechanisms, and prevention strategies for cardiotoxicity associated with some of the commonly known cytotoxic agents and the role of nuclear cardiac imaging in its monitoring and prevention, along with recent advances in this area.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.